TEANECK, N.J., April 10, 2012 /PRNewswire/ -- Herborium Group,
Inc., (PINKSHEETS: HBRM) www.herborium.com, a Botanical
Therapeutics® company, announced today that it has
partnered with KAMASUTRA (USA),
LLC to commercialize their unique natural herbs vodka
product in the Fall of 2012. The vodka formula, label and
packaging have already been approved by TTB (Alcohol and Tobacco
Tax and Trade Bureau). Market share for vodka in the
USA is $4.8 Billion in
annual sales with both on premise and home consumption on a rise.
This market does not include any additional potential from
the broader liquor market, whose consumers search out innovation
and alternative choices in all the products and services they
purchase. KAMASUTRA (USA)
LLC is a US partner of the German Bismarck Premium Brands GmbH
www.bismarck.de and
http://www.bismarck.de/kamasutra/englisch/kamasutra_ginseng_vodka.html.
The US version of the product will contain Herborium proprietary
herbal formula derived from the Company's sexual health
formulations know-how.
In addition to revenue participation and licensing fees to be
received by Herborium Group, the label of each 750ML bottle of the
product as well as vodka promotional materials, will
include the link to Herborium proprietary sexual health
Botanical Therapeutics® providing unprecedented exposure
and promotional opportunity. The market for
pharmaceutical sexual health products is over 3.2 billion
worldwide. The market for natural sexual health products is
estimated to be over $1.5 billion,
and growing.
In addition there is a growing need for women's sexual health
products. The female rsexual enhancement industry is expected to
grow into a multibillion dollar business as women themselves become
increasingly aware of their sexuality and their sexual health.
There is no Viagra comparative product on the market for women and
Herborium's Lasting Pleasure® for Women is the ONLY product
of its kind.
The sexual enhancement products' trajectory is for long term
growth, as is the market for the innovative natural-herbs
Vodka segment.
"As CEO of Kamasutra (USA),
LLC, I am passionately looking forward to working with Dr.
Agnes P. Olszewski and Herborium
Group as I see our combined efforts behind Kamasutra and all that
it stands for to be an extraordinary business opportunity, while
also a validation of how the experiences of two successful careers
in two diverse categories, alcoholic beverages and herbal products
when intimately combined, result in something even better for the
benefit of satisfying a market desire that we both have identified
from our separate strategic viewpoints." Tom Wilen, Kamasutra (USA), LLC CEO
Dr. Agnes Olszewski, Chairman and
CEO of Herborium stated: "I believe that this is a great
opportunity for Herborium to extend the reach of its herbal
know-how to another sector while supporting commercialization of
our sexual health products and growing our revenues and brand
recognition. We are lucky to partner with such high profile
companies as Kamasutra (USA) LLC
and Bismarck Premium Brands GmbH, and to benefit from an enormous
industry experience represented by Tom
Wilen."
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company uses clinical validation to establish
and maintain a differential advantage. The company markets its
products in the US and Europe. For
more information, please visit www.herborium.com and
www.acnease.com.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are based
on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends." We
cannot promise future returns. Our statements reflect our best
judgment at the time, and we disclaim any obligation to update or
alter forward-looking statements as the result of new information
or future events. The Company urges investors to review the risks
and uncertainties contained within its filings with the OTC Markets
and/or Securities and Exchange Commission.
For more information please inquire:
Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.